857 reports of this reaction
1.5% of all ABALOPARATIDE reports
#16 most reported adverse reaction
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES is the #16 most commonly reported adverse reaction for ABALOPARATIDE, manufactured by Radius Health, Inc.. There are 857 FDA adverse event reports linking ABALOPARATIDE to LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES. This represents approximately 1.5% of all 58,437 adverse event reports for this drug.
Patients taking ABALOPARATIDE who experience loss of personal independence in daily activities should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES is a less commonly reported adverse event for ABALOPARATIDE, but still significant enough to appear in the safety profile.
In addition to loss of personal independence in daily activities, the following adverse reactions have been reported for ABALOPARATIDE:
The following drugs have also been linked to loss of personal independence in daily activities in FDA adverse event reports:
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES has been reported as an adverse event in 857 FDA reports for ABALOPARATIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES accounts for approximately 1.5% of all adverse event reports for ABALOPARATIDE, making it a notable side effect.
If you experience loss of personal independence in daily activities while taking ABALOPARATIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.